Skip to main content

Table 1 Associations of genetically predicted bioavailable testosterone in men and of genetically predicted total testosterone in women with CKD and kidney function using univariable Mendelian randomization in the UK Biobank

From: The role of testosterone in chronic kidney disease and kidney function in men and women: a bi-directional Mendelian randomization study in the UK Biobank

Outcome

Exposure

#SNPs

Sex

OR

95% CI

p

 CKD

Genetically predicted bioT

125

Men

1.17

1.03, 1.33

0.01

Genetically predicted TT

254

Women

1.02

0.92, 1.14

0.68

 Albuminuria

Genetically predicted bioT

125

Men

1.15*

1.04, 1.27

0.008

Genetically predicted TT

254

Women

0.96

0.88, 1.06

0.43

    

Beta

95% CI

p

 eGFR_cr (ml/min per 1.73 m2)

Genetically predicted bioT

125

Men

− 1.70*

− 2.09, − 1.31

2.4 × 10−14

Genetically predicted TT

254

Women

− 0.24*

− 0.49, 0.02

0.07

 eGFR_crcys (ml/min per 1.73 m2)

Genetically predicted bioT

125

Men

− 1.27*

− 1.62, − 0.91

1.0 × 10−10

Genetically predicted TT

254

Women

0.12*

− 0.14, 0.39

0.36

  1. bioT bioavailable testosterone, CKD chronic kidney disease, eGFR estimated glomerular filtration rate, TT total testosterone
  2. *Mendelian randomization pleiotropy residual sum and outlier (MR-PRESSO) was used for the analysis; otherwise, inverse variance weighting was used